Purpose/Objectives In a relevant proportion of patients undergoing myocardial firstpass perfusion cardiac magnetic resonance (FPPCMR) inadequate adenosine stress may occur. This may cause falsenegative results and a suboptimal clinical management. “Splenic switchoff” has recently been proposed as a sign to detect effective adenosine response after firstpass imaging is performed. Novel methods are emerging to detect reduction of splenic blood volume during adenosine stress and prior to contrast administration. We sought to determine the feasibility of using splenic T2mapping as a marker to assess adenosinestress effect. Methods and Materials Fiftyfive consecutive patients (29 males, mean age 56.1±11.5) with clinical indications underwent FPPCMR at 1.5T (n=16) and 3T (n=39). Splenic T1 and T2values were assessed, using respectively MOLLI and FLASH sequences, performed at rest and during adenosine stress (140μg/kg/min, 4 min) along one midventricular shortaxis slice. Changes of T1 (ΔT1) and T2values (ΔT2) were calculated and expressed as percentages. FPPCMR was performed after intravenous injection of gadobutrol (0.1mmol/kg bodyweight). Images were analyzed with the use of a semiautomatic software (Circle CMR42, Calgary, Canada) to quantify splenic and myocardial enhancement. Spleentomyocardium perfusion ratio (s/mΔSI) was calculated to obtain splenic relative enhancement during FPPCMR. The presence of “switch off” sign was evaluated in consensus by two readers and used as standard of reference. Accuracy of s/mΔSI, ΔT1 and ΔT2 in predicting the splenic switchoff sign was assessed. Results Mean splenic rest native T1 and T2values were respectively 1256.7±96.5(ms) and 60.3±11(ms) at 3T, and 1149.1±75.1(ms) and 80±10.1(ms) at 1.5T, versus stress native T1 and T2values of 1198.5±85.8(ms) and 54.1±11.2(ms) at 3T, and 1100.4±85.1(ms) and 73.3±10.9(ms) at 1.5T (all p<0.001). Splenic relative enhancement (s/mΔSI) showed a correlation of 0.701 and 0.504 respectively with ΔT2 and ΔT1 (all p<0.001). The best accuracy for predicting “switchoff” sign was obtained with ΔT2 (AUC=0.987), followed by s/mΔSI (AUC=0.962) and ΔT1 (AUC=0.912) (all p<0.001) (Fig.1). The largest difference in terms of accuracy was observed between ΔT2 and ΔT1 (0.0732; p=0.076). Cutoffs were 8.3% for ΔT2 (sensitivity: 95%; specificity 94%) and 3.6% for ΔT1 (sensitivity: 84%; specificity: 83%). Conclusion Splenic T2mapping may be a helpful tool to predict splenic “switchoff” sign in FPPCMR. This may be useful to predict an effective adenosine response and, eventually, to allow for preventive dose adaption and less falsenegative results.
A new method for predicting splenic „switch-off“ sign: Splenic T2-mapping
T. D'angelo
;S. Mazziotti;A. Blandino;G. Cicero;
2018-01-01
Abstract
Purpose/Objectives In a relevant proportion of patients undergoing myocardial firstpass perfusion cardiac magnetic resonance (FPPCMR) inadequate adenosine stress may occur. This may cause falsenegative results and a suboptimal clinical management. “Splenic switchoff” has recently been proposed as a sign to detect effective adenosine response after firstpass imaging is performed. Novel methods are emerging to detect reduction of splenic blood volume during adenosine stress and prior to contrast administration. We sought to determine the feasibility of using splenic T2mapping as a marker to assess adenosinestress effect. Methods and Materials Fiftyfive consecutive patients (29 males, mean age 56.1±11.5) with clinical indications underwent FPPCMR at 1.5T (n=16) and 3T (n=39). Splenic T1 and T2values were assessed, using respectively MOLLI and FLASH sequences, performed at rest and during adenosine stress (140μg/kg/min, 4 min) along one midventricular shortaxis slice. Changes of T1 (ΔT1) and T2values (ΔT2) were calculated and expressed as percentages. FPPCMR was performed after intravenous injection of gadobutrol (0.1mmol/kg bodyweight). Images were analyzed with the use of a semiautomatic software (Circle CMR42, Calgary, Canada) to quantify splenic and myocardial enhancement. Spleentomyocardium perfusion ratio (s/mΔSI) was calculated to obtain splenic relative enhancement during FPPCMR. The presence of “switch off” sign was evaluated in consensus by two readers and used as standard of reference. Accuracy of s/mΔSI, ΔT1 and ΔT2 in predicting the splenic switchoff sign was assessed. Results Mean splenic rest native T1 and T2values were respectively 1256.7±96.5(ms) and 60.3±11(ms) at 3T, and 1149.1±75.1(ms) and 80±10.1(ms) at 1.5T, versus stress native T1 and T2values of 1198.5±85.8(ms) and 54.1±11.2(ms) at 3T, and 1100.4±85.1(ms) and 73.3±10.9(ms) at 1.5T (all p<0.001). Splenic relative enhancement (s/mΔSI) showed a correlation of 0.701 and 0.504 respectively with ΔT2 and ΔT1 (all p<0.001). The best accuracy for predicting “switchoff” sign was obtained with ΔT2 (AUC=0.987), followed by s/mΔSI (AUC=0.962) and ΔT1 (AUC=0.912) (all p<0.001) (Fig.1). The largest difference in terms of accuracy was observed between ΔT2 and ΔT1 (0.0732; p=0.076). Cutoffs were 8.3% for ΔT2 (sensitivity: 95%; specificity 94%) and 3.6% for ΔT1 (sensitivity: 84%; specificity: 83%). Conclusion Splenic T2mapping may be a helpful tool to predict splenic “switchoff” sign in FPPCMR. This may be useful to predict an effective adenosine response and, eventually, to allow for preventive dose adaption and less falsenegative results.Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.